Mariana C. Castells, MD, PhD, Harvard Medical School, discusses mast cells. Dr Castells reviews the impact of mast cells on allergic reactions to food allergies and vaccines, and also discuss mast cell activation syndrome. Innovative treatments related to drug desensitization and allergy management are also discussed.
Systemic mastocytosis with associated hematologic neoplasm (SM-AHN) presents unique diagnostic and treatment challenges. In this Medscape-certified activity, experts discuss the complex patient journey, from delayed diagnosis to individualized…
Avapritinib, branded as Ayvakit, became the first FDA-approved treatment for indolent systemic mastocytosis (ISM) in 2023, marking a major advancement for patients. ISM, driven by the KIT D816V…
Systemic mastocytosis, a rare blood disorder, affects the entire body. There are many challenges associated with living with this systemic mastocytosis that are centered around reducing the frequency…